Back to search

Article

The expression of PKM1 and PKM2 in developing, benign, and cancerous prostatic tissues

2023-09-29

Abstract excerpt

Neuroendocrine prostate cancer (NEPCa) is the most aggressive type of prostate cancer. However, energy metabolism, one of the hallmarks of cancer, in NEPCa has not been well studied. Pyruvate kinase M (PKM), which catalyzes the final step of glycolysis, has two main splicing isoforms, PKM1 and PKM2. PKM2 is known to be upregulated in various cancers, including prostate adenocarcinoma (AdPCa). In this study, we use...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4bcaceb6-743b-5ef2-9d43-19f7fb973b17
DOI
10.1101/2023.09.27.559832
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The expression of PKM1 and PKM2 in developing, benign, and cancerous prostatic tissuesDOI 10.1101/2023.09.27.559832
Select a neighboring publication to make it the new centre.